CS logo
small CS logo
SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF

Sankt Peterburg, Leningrad, Russian Federation
Государственный университет в Санкт-Петербурге

About SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF


Первый Санкт-Петербургский государственный медицинский университет имени И. П. Павлова — федеральное государственное бюджетное образовательное учреждение высшего образования Министерства здравоохранения Российской Федерации. До сегодняшнего дня вуз сменил несколько названий: Женский медицинский институт.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
7
Hoffmann-La Roche
7
Gilead Sciences
3
Kowa Research Europe
3
Novartis
1
Total Rows: 5

Clinical Trials at SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF


During the past decade, SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years112233001133000000113322Started TrialsCompleted Trails20152016201720182019202001234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
857
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)
2008-09-01
2011-04-01
Completed
349
A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)
2008-12-12
2017-07-27
Completed
2,825
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
2008-12-03
2017-11-13
Completed
1,314
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
2011-11-01
2013-10-01
Completed
465
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
2012-01-01
2013-08-01
Completed
431

Rows per page:

1–21 of 21

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" #1 sponsor was "Boehringer Ingelheim" with 7 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Kowa Research Europe" with 3 trials sponsored and "Novartis" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 7Boehringer Ingelheim: 7Hoffmann-La Roche: 7Hoffmann-La Roche: 7Gilead Sciences: 3Gilead Sciences: 3Kowa Research Europe: 3Kowa Research Europe: 3Novartis: 1Novartis: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 1Eli Lilly and Company: 1

Clinical Trials Conditions at SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF


According to Clinical.Site data, the most researched conditions in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" are "Dyslipidemia" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" in a lesser frequency.

Clinical Trials Intervention Types at SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF


Most popular intervention types in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" are "Drug" (20 trials), "Behavioral" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Atezolizumab" (3 trials), "Diet" (3 trials), "Exercise" (3 trials) and "Pitavastatin" (3 trials). Other intervention names were less common.

Clinical Trials Genders at SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF


The vast majority of trials in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" are 20 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF


Currently, there are NaN active trials in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 17Phase 3: 17Phase 2: 2Phase 2: 2Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 17Completed: 17Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1

Departments of SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF


SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF has several departments that took part in Clinical trials: "RM Gorbacheva Research Institute" - 10 trials
Departments List
Name
City
Trials
Total Rows: 1